BioMarin Pharmaceuticals
BMRN
BMRN
499 hedge funds and large institutions have $15B invested in BioMarin Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 184 increasing their positions, 164 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 467 → 499 (+32)
1.85% more ownership
Funds ownership: 96.62% → 98.47% (+1.8%)
2% more capital invested
Capital invested by funds: $14.7B → $15B (+$288M)
Holders
499
Holding in Top 10
11
Calls
$139M
Puts
$101M
Top Buyers
| 1 | +$185M | |
| 2 | +$132M | |
| 3 | +$128M | |
| 4 |
Jennison Associates
New York
|
+$101M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$94.9M |
Top Sellers
| 1 | -$215M | |
| 2 | -$153M | |
| 3 | -$137M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$60.5M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$41.1M |